Joint statement on Savvy Phase 3 trial in Ghana to test the effectiveness of Savvy Gel in preventing HIV

Research Triangle Park, NC and Huntingdon Valley, PA -- International efforts are underway to evaluate microbicides as a tool to prevent HIV infection in people at high risk. As part of this initiative, with funding from the U.S. Agency for International Development (USAID), Family Health International (FHI) and Cellegy Pharmaceuticals, Inc. have been working to see if a vaginal gel called Savvy is effective in preventing male-to-female transmission of HIV among women at high risk of infection in West Africa. Other organizations are conducting trials in the United States to determine if Savvy is effective as a contraceptive.

Family Health International and Cellegy Pharmaceuticals announced today that they plan to stop the HIV prevention trial of Savvy being conducted by FHI in Ghana. This decision followed a recommendation of the study's external, independent Data Monitoring Committee (DMC). The DMC reviewed the study data to date and concluded that, while there is no evidence of safety concerns based on the comparative HIV infection rates in the Savvy and placebo groups, the Ghana study would be unable to evaluate the effectiveness of the product.

The Savvy Phase 3 clinical trial in Ghana began recruitment in March 2004 and completed planned enrollment with 2,142 women in June 2005. Half of the women were given Savvy gel, and half were given a placebo gel to be inserted vaginally with pre-filled applicators. At monthly visits during each woman's year-long follow-up, each participant was tested for HIV and reported on use of the gel and any side effects or medical problems. Each participant received counseling for reducing her risk of HIV and was given condoms for use during all sexual acts. Eighteen months into the study, the observed HIV incidence in the cohort was about one-third the rate expected prior to the study.

"The reason we decided to stop the trial was that the group of women who volunteered to participate had such a low inciden

Contact: Beth Robinson
Rational PR

Page: 1 2 3

Related medicine news :

1. Joint Principles of PC-MH released by organizations representing more than 300,000 physicians
2. AHA statement recommends doctors change approach
3. CHPA statement regarding Monitoring the Future findings on cough medicine abuse
4. International AIDS Vaccine Initiative statement on male circumcision
5. AASM position statement: Treating insomnia with over-the-counter sleep aids, herbal supplements
6. American Thoracic Society publishes new statement on hepatotoxicity of antituberculosis therapy
7. NHLBI and NIH statements on totally implanted permanent artificial heart
8. ESC statement on the CHARISMA trial on Clopidogrel (Plavix)
9. ESC issues policy statement on reperfusion therapy
10. American Dietetic Association statement on new MyPyramid
11. GSK announces launch of largest ever Phase III trial in lung cancer treatment

Post Your Comments:

(Date:8/21/2019)... SAN ANTONIO (PRWEB) , ... August 21, 2019 , ... ... in skin care products. This water-based ingredient is currently used in skincare products such ... with PPT. The award-winning product addresses the growing need to protect the skin from ...
(Date:8/21/2019)... ... August 21, 2019 , ... Future residents got their ... Phase II expansion of Providence Point in Pittsburgh’s Scott Township neighborhood involved additions, ... the 70-unit apartment tower, Hamilton Tower. , The expansion began two ...
(Date:8/19/2019)... MEADOWS, Ill. (PRWEB) , ... August 19, 2019 ... ... performed more than 12.5 million medically necessary and cosmetic procedures in 2018 – ... Now in its seventh year, the 2018 ASDS Survey on Dermatologic Procedures ...
(Date:8/19/2019)... , ... August 19, 2019 , ... A July 26 ... dog owners should be brushing their pets’ teeth twice a day. The acknowledges that, ... the time and suggests that close monitoring and brushing at least twice a week ...
(Date:8/17/2019)... ... August 17, 2019 , ... Approximately 50 area ... services today under a program sponsored by United Concordia Dental and Mission Arlington/Metroplex. ... work alongside them to make these services available to area youths who are ...
Breaking Medicine News(10 mins):
(Date:8/21/2019)... ... August 21, 2019 , ... Dr. Leonard Bley at ... newest laser ReLEx® SMILE (Small Incision Lenticule Extraction) located in their state-of-the-art Manhattan surgery ... SMILE in the Tri-State area. SMILE is a one-step, one laser procedure that is ...
(Date:8/21/2019)... ... 21, 2019 , ... Impact Advisors , a leading provider of clinical, ... has been named to Inc. magazine’s Inc. 5000 list. The Inc. 5000 list is ... percentage revenue growth. This year the firm was also named a 5-Time Inc. 5000 ...
(Date:8/19/2019)... (PRWEB) , ... August 18, 2019 , ... Laurence Fishburne ... all ages across the globe. His work spans genres and generations. On television, he ... a series that covers topics important to today's world and gives viewers information in ...
Breaking Medicine Technology:
Cached News: